Blog

On September 24, 2009, a hearing was held in Richmond, Virginia before the National Panel on Multi-District Litigation with regard the lawsuits that have been filed against the manufacturers of YAZ, Yasmin and Ocella.  This Panel of federal judges who oversee the establishment and coordination of mass torts litigation within […]

A recent study published by scientists in Victoria, Australia provides even more compelling evidence that post-operative use of pain pumps in patients undergoing shoulder surgeries is a bad idea.   A number of researchers have noted that patients who utilized post-operative pain pumps which bathed their shoulder joints with anesthetic drugs […]

I saw recently that a U.S. Senator had sponsored a bill to have the FDA regulate the Tobacco companies.  According to an article in June 12, 2009 Washington Post newspaper, the bill was sponsored by Massachusetts Sen. Edward M. Kennedy. It seems the FDA has had poor success in regulating […]

Levaquin (also known as levofloxacin) is a popular antibiotic that has been used for years for the treatment of upper respiratory infections, urinary tract infections, prostatitis, and bacterial infections.  It is part of a class of drugs known as fluoroquinolones, which were first marketed in the United States in 1997.  […]

Merck’s nightmare over Vioxx continues.  This is one that has cost the company dearly – on Wall Street, among physicians, in scientific circles, in the judicial system, and in the court of public opinion.  The latest blow came from the New England Journal of Medicine which published additional information regarding […]

A novel lawsuit is winding its way through the courts in St. Louis.  Thirty Missouri hospitals are pursuing claims against Altria (the parent company of Phillip Morris) and other tobacco manufacturers for the costs of medical care provided to patients with tobacco-induced diseases who were uninsured or unable to pay […]

A recent study published in Kidney International, the journal of the International Society of Nephrology, noted increasing concerns over the use of gadolinium-based contrast agents in patients with renal or liver disease.  In this article, researchers from the Oregon Health and Science University urged the use of ultrasmall superparamagnetic iron […]

A September of 2008 study published in the journal Radiology, sought to further identify those patients most at risk for the development of nephrogenic systemic fibrosis (NSF) as a result of exposure to gadolinium-based contrast agents.  Nephrogenic systemic fibrosis is an incurable, devastating disease that manifests itself as significant skin […]

A very dear friend once told me to be careful what you write in a letter, because it could come back to haunt you in the future.  That advice was given to me in the early 1980’s by the CEO of a company in my hometown of Reading, Pennsylvania.  We […]

More than six years after the Women’s Health Initiative Study was suspended due concerns regarding the long-term health risks associated with the drugs new information continues to emerge. The newest evidence, published in the Archives of Internal Medicine, was noted in the Nurses’ Health Study, a study involving 51,637 postmenopausal nurses […]